Key result
Machine learning consistently identifies 10 significant genetic variants linked to HCM.
Why the study?
Hypertrophic cardiomyopathy has strong genetic foundations, but few studies have addressed the complex network of co-expressed genes and variants modifying the phenotype.
Can machine learning techniques identify relevant genetic variants and their interactions in patients with hypertrophic cardiomyopathy?
Case-Control (n=128)
Can machine learning techniques identify relevant genetic variants and their interactions in patients with hypertrophic cardiomyopathy?
Machine learning techniques can effectively identify disease-associated genetic variants and potential disease modulators in hypertrophic cardiomyopathy.
Hypothesis-generating for variant prioritization in hypertrophic cardiomyopathy; validation required before clinical use.
Hypertrophic cardiomyopathy is known to have strong genetic foundations. However, only some studies have addressed the complex network of co-expressed genes and variants that modify the phenotype. Machine learning methods offer robust information discovery when dealing with high-dimensional datasets. We aimed to perform relevance and interaction analysis on genetic variants from hypertrophic cardiomyopathy patients using diverse machine learning techniques, with the following stages: (a) Statistical univariate techniques (with various p-value adjustment methods) identified relevant variants; (b) Linear classifiers (support vector machines, Fisher discriminant analysis) provided combined relevance based on feature weights; (c) Informative variable identifier method and Bayesian networks explained inter-variant relationships; (d) Manifold learning of low-dimensional latent spaces gave interpretable representations of groups; (e) Linkage disequilibrium matrices and frequency tables discovered associations between variants. We analyzed 61 patients and 67 controls with genetic information comprising 216 variants from a genetic panel of 15 genes. Across all methodologies, ten variants were consistently identified as significant, with 22 total variants significant in at least three out of five methods. Machine learning has been found to detect disease-associated variants, including pathogenic founder variants (11:47357494, 11:47360070, 11:47372137). This methodology allows for identifying potential disease modulators while accounting for relevance and interactions among variants.
No takes yet. Share an insight, caveat, or question.
Lozano-Paredes et al. (2025) conducted a case-control in Hypertrophic cardiomyopathy (n=128). Machine learning techniques vs. Controls was evaluated on Identification of significant genetic variants. Machine learning techniques consistently identified 10 significant genetic variants, and 22 variants significant in at least 3 of 5 methods, out of 216 variants in hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: